Effectiveness of CRD-740 in Heart Failure

Clinical trial NCT05409183 · TERMINATED

Trial details

NCT number: NCT05409183
Sponsor: Cardurion Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure Heart Failure With Reduced Ejection Fraction Heart Failure With Preserved Ejection Fraction Cardiovascular Diseases Heart Diseases

Start date: 2022-05-26
Primary completion: 2023-05-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.